Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 2Sarcoma, Synovial 1Rhabdoid Tumor 1Neoplasms 1Mesothelioma, Malignant 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

Crizotinib 2Bone Marrow Transplantation 23-Iodobenzylguanidine 2vorasidenib 1tucatinib 1tovorafenib 1tazemetostat 1taletrectinib 1olaparib 1nirogacestat 1glucarpidase 1enzalutamide 1denileukin diftitox 1copanlisib 1balstilimab 1atezolizumab 1adagrasib 1Proton Pump Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1LY3023414 1Hydrocortisone 1Carboxypeptidases 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Neoplasms × tazemetostat × Clear all
NCT04225429 2024-10-01

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Ipsen

No longer available
Sarcoma

Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡